| Q35890025 | A Network Model to Describe the Terminal Differentiation of B Cells |
| Q92234882 | A Regulatory Circuit Controlling the Dynamics of NFκB cRel Transitions B Cells from Proliferation to Plasma Cell Differentiation |
| Q33934987 | A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translation |
| Q35825984 | A germinal center-independent pathway generates unswitched memory B cells early in the primary response |
| Q33240316 | A library of gene expression signatures to illuminate normal and pathological lymphoid biology |
| Q42824972 | A new functional domain of Bcl6 family that recruits histone deacetylases |
| Q33228615 | A peptide aptamer to antagonize BCL-6 function. |
| Q24300928 | A putative silencer element in the IL-5 gene recognized by Bcl6 |
| Q28590572 | ADAR1 protein induces adenosine-targeted DNA mutations in senescent Bcl6 gene-deficient cells |
| Q35950048 | Aberrant regulation of hematopoiesis by T cells in BAZF-deficient mice |
| Q40976625 | Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L). |
| Q28279743 | Aggressive lymphomas |
| Q36387183 | Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes |
| Q55428229 | Allergic TH2 Response Governed by B-Cell Lymphoma 6 Function in Naturally Occurring Memory Phenotype CD4+ T Cells. |
| Q34019039 | Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patient |
| Q38334286 | Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation |
| Q35055621 | Ambivalent role of BCL6 in cell survival and transformation |
| Q35088890 | An incoherent regulatory network architecture that orchestrates B cell diversification in response to antigen signaling. |
| Q35887152 | Antigen-specific antibody responses in B-1a and their relationship to natural immunity |
| Q35209481 | Are follicular dendritic cells really good for nothing? |
| Q35102310 | B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells |
| Q61449528 | B-Cell Lymphoma 6 (BCL6) Is a Host Restriction Factor That Can Suppress HBV Gene Expression and Modulate Immune Responses |
| Q38170804 | BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint |
| Q24522565 | BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor |
| Q33917162 | BCL-6 in the pathogenesis of non-Hodgkin's lymphoma |
| Q40639572 | BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation |
| Q36322298 | BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci |
| Q74268408 | BCL-6 regulates chemokine gene transcription in macrophages |
| Q55034216 | BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. |
| Q91689214 | BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress |
| Q47269833 | BCL6 as a therapeutic target for lymphoma |
| Q37352854 | BCL6 cooperates with CD40 stimulation and loss of p53 function to rapidly transform primary B cells |
| Q54774359 | BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma |
| Q60921238 | BCL6 inhibition: a chronic GVHD twofer |
| Q44526157 | BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells |
| Q37256816 | BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma |
| Q33836309 | BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes |
| Q22254616 | BCoR, a novel corepressor involved in BCL-6 repression |
| Q38196695 | BTB-ZF transcription factors, a growing family of regulators of early and late B-cell development |
| Q38712033 | Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells |
| Q28592364 | Bcl6 controls granzyme B expression in effector CD8+ T cells |
| Q28216493 | Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program |
| Q39153232 | Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway |
| Q36943399 | Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6. |
| Q37003485 | Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas |
| Q37585210 | Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation |
| Q37338162 | Critical roles of mTOR Complex 1 and 2 for T follicular helper cell differentiation and germinal center responses. |
| Q39111609 | Cutting Edge: IL-10 Is Essential for the Generation of Germinal Center B Cell Responses and Anti-Plasmodium Humoral Immunity |
| Q90522892 | Cutting Edge: T Cell-Dependent Plasmablasts Form in the Absence of Single Differentiated CD4+ T Cell Subsets |
| Q38781630 | Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component |
| Q47933757 | Cytokine regulation of secondary lymphoid organ development. |
| Q37589643 | Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage. |
| Q33706071 | Deficiency of the transcriptional repressor B cell lymphoma 6 (Bcl6) is accompanied by dysregulated lipid metabolism |
| Q52861941 | Determining the Origin of Human Germinal Center B Cell-Derived Malignancies. |
| Q37831694 | Development of PLZF-expressing innate T cells |
| Q41889503 | Development of chronic allergic responses by dampening Bcl6-mediated suppressor activity in memory T helper 2 cells |
| Q28585295 | Differential gene expression between sensory neocortical areas: potential roles for Ten_m3 and Bcl6 in patterning visual and somatosensory pathways |
| Q37117559 | Distinct regulation of effector and memory T-cell differentiation. |
| Q27860529 | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling |
| Q46918689 | Diversity among memory B cells: origin, consequences, and utility. |
| Q36949937 | Dynamic changes in Id3 and E-protein activity orchestrate germinal center and plasma cell development. |
| Q35198527 | Dynamic expression of BCL6 in murine conventional dendritic cells during in vivo development and activation |
| Q37265004 | Effect of antipyretic analgesics on immune responses to vaccination |
| Q36646675 | Enhanced susceptibility to Citrobacter rodentium infection in microRNA-155-deficient mice |
| Q33741881 | Epitope Density Influences CD8+ Memory T Cell Differentiation |
| Q41827741 | Evolution of two prototypic T cell lineages. |
| Q34403006 | Expansion or depletion of T follicular helper cells during HIV infection: consequences for B cell responses |
| Q90449645 | Ex vivo synthetic immune tissues with T cell signals for differentiating antigen-specific, high affinity germinal center B cells |
| Q27021855 | Factors regulating immunoglobulin production by normal and disease-associated plasma cells |
| Q37408346 | Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment |
| Q40591996 | Gene Expression Profiles of Cutaneous B Cell Lymphoma |
| Q34207536 | Gene expression physiology and pathophysiology of the immune system |
| Q39761197 | Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming |
| Q104073425 | Genetic and epigenetic determinants of diffuse large B-cell lymphoma |
| Q33860606 | Genomic-scale gene expression profiling of normal and malignant immune cells |
| Q37899118 | Germinal center B and follicular helper T cells: siblings, cousins or just good friends? |
| Q47933820 | Germinal centers: form and function. |
| Q52164738 | HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody in mice. |
| Q42995395 | Hepatitis C virus structural proteins induce liver cell injury in transgenic mice |
| Q90501746 | Histone deacetylase 3 controls a transcriptional network required for B cell maturation |
| Q58845447 | Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design |
| Q40888830 | IgG-Immune Complexes Promote B Cell Memory by Inducing BAFF |
| Q35561022 | Impact of developmental lead exposure on splenic factors |
| Q30437109 | Imprinting the fate of antigen-reactive B cells through the affinity of the B cell receptor. |
| Q39639974 | Inhibition of Terminal Differentiation of B Cells Mediated by CD27 and CD40 Involves Signaling through JNK |
| Q44183065 | Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice |
| Q34011554 | Internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma |
| Q36060329 | Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions |
| Q38952749 | Lifelong memory responses perpetuate humoral TH2 immunity and anaphylaxis in food allergy. |
| Q36703936 | Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms |
| Q36985671 | Long-lived antigen-induced IgM plasma cells demonstrate somatic mutations and contribute to long-term protection. |
| Q34162187 | Lymphoid malignancies: the dark side of B-cell differentiation |
| Q28589356 | M17, a gene specific for germinal center (GC) B cells and a prognostic marker for GC B-cell lymphomas, is dispensable for the GC reaction in mice |
| Q37936211 | Malignant pirates of the immune system |
| Q35094433 | Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis |
| Q38632961 | Mechanisms of action of BCL6 during germinal center B cell development |
| Q28510456 | Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells |
| Q37355322 | Mesenchymal stem cells suppress B-cell terminal differentiation. |
| Q39580400 | MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts. |
| Q30661985 | Molecular definition of the germinal centre stage of B-cell differentiation |
| Q36355035 | Murine germinal center B cells require functional Fms-like tyrosine kinase 3 signaling for IgG1 class-switch recombination |
| Q37621244 | New insights into the differentiation and function of T follicular helper cells. |
| Q28208750 | Non-immunoglobulin/BCL6 gene fusion in diffuse large B-cell lymphoma: prognostic implications |
| Q28587370 | Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice |
| Q36528999 | Not-so-great expectations: re-assessing the essence of T-cell memory. |
| Q33889407 | OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development |
| Q34303639 | Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. |
| Q38239866 | Orchestration of plasma cell differentiation by Bach2 and its gene regulatory network |
| Q22010549 | Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci |
| Q41824952 | PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells |
| Q34245261 | Pathogenesis of human B cell lymphomas |
| Q36570655 | Pax5--a critical inhibitor of plasma cell fate |
| Q89777332 | Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways |
| Q36371613 | Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine |
| Q33901171 | Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis |
| Q40975965 | Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma |
| Q37415251 | Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin |
| Q102075398 | Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus |
| Q34949637 | Regulation of cell differentiation by the DNA damage response |
| Q34498083 | Regulation of gene expression by the proto-oncogene BCL-6. |
| Q33811750 | Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. |
| Q28593586 | Repression of an interleukin-4-responsive promoter requires cooperative BCL-6 function |
| Q34129480 | Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells |
| Q36834537 | Role of the Transcriptional Repressor BCL6 in Allergic Response and Inflammation. |
| Q33369857 | Role of the transcriptional corepressor Bcor in embryonic stem cell differentiation and early embryonic development |
| Q36677337 | STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. |
| Q45265413 | STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression |
| Q41935260 | Signals that drive T-bet expression in B cells |
| Q37682640 | Signals that influence T follicular helper cell differentiation and function. |
| Q34376859 | Signatures of the immune response |
| Q57044016 | Small-molecule BCL6 inhibitor effectively treats mice with non-sclerodermatous chronic graft-versus-host disease |
| Q40836930 | Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. |
| Q34958560 | Surviving the crash: transitioning from effector to memory CD8+ T cell |
| Q34569062 | Switching to BCL-6 Negativity in Relapsed Diffuse Large B Cell Lymphoma Correlated with More Aggressive Disease Course |
| Q38728585 | Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells? |
| Q34646572 | Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis |
| Q34175167 | The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers |
| Q37928818 | The BTB-ZF family of transcription factors: key regulators of lineage commitment and effector function development in the immune system |
| Q33569863 | The BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity |
| Q38034839 | The BTB-ZF transcription factors |
| Q33794960 | The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. |
| Q41661129 | The Complex Interplay between DNA Injury and Repair in Enzymatically Induced Mutagenesis and DNA Damage in B Lymphocytes. |
| Q36110104 | The Drosophila BCL6 homolog Ken and Barbie promotes somatic stem cell self-renewal in the testis niche |
| Q39018438 | The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target |
| Q34593830 | The Long Winding Road toward Understanding the Molecular Mechanisms for B-Cell Suppression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin |
| Q38919518 | The PI3K pathway in B cell metabolism |
| Q36991440 | The expansion and maintenance of antigen-selected CD8(+) T cell clones |
| Q24292242 | The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma |
| Q24531167 | The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis |
| Q34378402 | The immune system and gene expression microarrays--new answers to old questions |
| Q34414672 | The occurrence and significance of V gene mutations in B cell-derived human malignancy |
| Q28216775 | The proto-oncogene BCL-6 in normal and malignant B cell development |
| Q50564001 | The proto-oncogene BCL6 promotes survival of olfactory sensory neurons. |
| Q28589662 | The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells |
| Q36528960 | The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells. |
| Q33900623 | The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma |
| Q38202086 | Tracking plasma cell differentiation and survival |
| Q89997630 | Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses |
| Q34547226 | Transcriptional control of B-cell development |
| Q35895816 | Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation |
| Q52021288 | Transcriptional regulation of memory B cell development. |
| Q100465086 | Transcriptional regulation of memory B cell differentiation |
| Q24554404 | Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching |
| Q34626885 | Transcriptional repressors, corepressors and chromatin modifying enzymes in T cell development |
| Q40901168 | Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas |
| Q102381678 | Using NMR spectroscopy in the fragment-based drug discovery of small-molecule anti-cancer targeted therapies |
| Q33536537 | V(D)J hypermutation and receptor revision: coloring outside the lines |
| Q37212132 | Vitamin A and retinoic acid in the regulation of B-cell development and antibody production |
| Q41485230 | YY1 Regulates the Germinal Center Reaction by Inhibiting Apoptosis |
| Q41986026 | ZBTB32 Restricts the Duration of Memory B Cell Recall Responses. |
| Q53617978 | miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2. |